Early research (Phase 1)Ended earlyNCT04458259What this trial is testingStudy of PF-07265807 in Participants With Metastatic Solid Tumors.Who this might be right forNeoplasm Metastasis Pfizer 88
Testing effectiveness (Phase 2)Study completedNCT05091346What this trial is testingE7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid TumorsWho this might be right forMelanomaCarcinoma, HepatocellularColorectal Neoplasms Eisai Inc. 89
Not applicableLooking for participantsNCT07318051What this trial is testingSample Collection for Ongoing Research and Product Evaluation StudyWho this might be right forBreast CancerLung CancerMuscle Invasive Bladder Cancer+9 more Natera, Inc. 9,600
Early research (Phase 1)Ended earlyNCT04042480What this trial is testingSGN-CD228A in Advanced Solid TumorsWho this might be right forCutaneous MelanomaPleural MesotheliomaHER2 Negative Breast Neoplasms+3 more Seagen Inc. 88
Early research (Phase 1)Ended earlyNCT06546553What this trial is testingLearn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.Who this might be right forNeoplasmsNon-small-cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+3 more Pfizer 10
Testing effectiveness (Phase 2)Looking for participantsNCT07070518What this trial is testingStudy of GV20-0251 in Participants With Solid Tumor MalignanciesWho this might be right forSolid Tumor CancerAdult Refractory CancerEndometrial Carcinoma (EC)+6 more GV20 Therapeutics 350
Early research (Phase 1)Study completedNCT00667641What this trial is testingPaclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+6 more University of Medicine and Dentistry of New Jersey 16
Early research (Phase 1)Looking for participantsNCT06839105What this trial is testingA Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced MalignanciesWho this might be right forNon-Small Cell Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Melanoma and Other Solid Tumor Shanghai Junshi Bioscience Co., Ltd. 214
Not applicableLooking for participantsNCT03787056What this trial is testingPredictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer PatientsWho this might be right forCancerBreast CancerGastric Cancer+14 more Hospices Civils de Lyon 410
Not applicableLooking for participantsNCT00001823What this trial is testingEvaluation for NCI Surgery Branch Clinical Research ProtocolsWho this might be right forSynovial Cell CancerMelanomaColorectal Cancer+2 more National Cancer Institute (NCI) 7,000
Testing effectiveness (Phase 2)Study completedNCT03190174What this trial is testingNivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain CancersWho this might be right forEwing SarcomaPEComaEpithelioid Sarcoma+11 more Sarcoma Oncology Research Center, LLC 34
Early research (Phase 1)Study completedNCT03517488What this trial is testingXmAb®20717 in Subjects With Selected Advanced Solid TumorsWho this might be right forMelanomaBreast CarcinomaHepatocellular Carcinoma+25 more Xencor, Inc. 150
Early research (Phase 1)Active Not RecruitingNCT05557045What this trial is testingJZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815Who this might be right forAdvanced CancerMetastatic CancerSolid Tumor+4 more Jazz Pharmaceuticals 98
Early research (Phase 1)Study completedNCT02387307What this trial is testingRSIFN-co in Subjects With Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small-Cell LungCarcinoma, Renal CellMelanoma+2 more Sichuan Huiyang Life Science and Technology Corporation 42
Not applicableStudy completedNCT02171286What this trial is testingThe Oncopanel Pilot (TOP) StudyWho this might be right forColorectal Cancer MetastaticAdvanced Non-Small Cell Lung CarcinomaAdvanced Melanoma+2 more British Columbia Cancer Agency 432
Early research (Phase 1)Study completedNCT00441337What this trial is testingMDX-1106 in Patients With Selected Refractory or Relapsed MalignanciesWho this might be right forCarcinoma, Non-Small-Cell LungColorectal CancerMalignant Melanoma+2 more Bristol-Myers Squibb 39
Not applicableLooking for participantsNCT07552467What this trial is testingSub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant TumorsWho this might be right forPancreatic CancerBreast CancerLung Cancer+5 more Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 26
Early research (Phase 1)Study completedNCT01638533What this trial is testingRomidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionWho this might be right forGliomaHematopoietic and Lymphoid Cell NeoplasmLymphoma+47 more National Cancer Institute (NCI) 37
Not applicableActive Not RecruitingNCT03285230What this trial is testingThe French E3N Prospective Cohort StudyWho this might be right forBreast CancerColo-rectal CancerParkinson Disease+11 more Institut National de la Santé Et de la Recherche Médicale, France 100,000
Early research (Phase 1)Ended earlyNCT02014116What this trial is testingLY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their BodyWho this might be right forNeoplasmsNeoplasm MetastasisMelanoma+2 more Eli Lilly and Company 51